WEST PHARMACEUTICAL SERVICES INC 4
4 · WEST PHARMACEUTICAL SERVICES INC · Filed Nov 17, 2014
Insider Transaction Report
Form 4
GAILEY JOHN R
VP, Gen. Counsel & Sec.
Transactions
- Sale
Common Stock
2014-11-13$52.41/sh−8,000$419,280→ 79,891.372 total - Exercise/Conversion
Common Stock
2014-11-13$21.34/sh+20,000$426,800→ 87,891.372 total - Sale
Common Stock
2014-11-13$52.36/sh−20,000$1,047,206→ 59,891.372 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-11-13$21.34/sh−20,000$426,800→ 17,832 totalExercise: $21.34From: 2011-03-22Exp: 2020-03-22→ Common Stock (20,000 underlying)
Holdings
- 1,463.37(indirect: By Savings Plan)
Common Stock
- 11,222.14(indirect: Non-Qualified Deferred Compensation Plan)
Common Stock
Footnotes (1)
- [F1]Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.